2022
DOI: 10.1016/j.jgar.2021.10.022
|View full text |Cite
|
Sign up to set email alerts
|

Global prevalence and molecular epidemiology of mcr-mediated colistin resistance in Escherichia coli clinical isolates: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
34
1

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(39 citation statements)
references
References 192 publications
4
34
1
Order By: Relevance
“…Colistin resistance, which is especially associated with mobile genetic elements, such as (mcr) genes, emerged as a major threat to the control of infections caused by Gram-negative bacteria. Dadashi et al (2021) investigated the global prevalence of mcr-mediated colistin-resistant E. coli clinical isolates in Oceania, Africa, America, Europe, and Asia, which were 0.32, 2.27, 5.19, 25.49, and 66.72, respectively. Their research included 79% of the works published between 2014 and 2020 ( Dadashi et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Colistin resistance, which is especially associated with mobile genetic elements, such as (mcr) genes, emerged as a major threat to the control of infections caused by Gram-negative bacteria. Dadashi et al (2021) investigated the global prevalence of mcr-mediated colistin-resistant E. coli clinical isolates in Oceania, Africa, America, Europe, and Asia, which were 0.32, 2.27, 5.19, 25.49, and 66.72, respectively. Their research included 79% of the works published between 2014 and 2020 ( Dadashi et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“… Dadashi et al (2021) investigated the global prevalence of mcr-mediated colistin-resistant E. coli clinical isolates in Oceania, Africa, America, Europe, and Asia, which were 0.32, 2.27, 5.19, 25.49, and 66.72, respectively. Their research included 79% of the works published between 2014 and 2020 ( Dadashi et al, 2021 ). Shen et al (2018) investigated 774 non-duplicate MCR-1-positive E. coli (MCRPEC) isolates from 774 stool samples collected from 5,159 healthy individuals in 30 provinces and municipalities in 2016, with MCRPEC prevalence ranging from 3.7 to 32.7% (average: 15.0%)—substantially higher than previously reported ( Shen et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…In particular, ST410 isolates have been reported in Asia (China and Vietnam), Europe (Italy), and America (Brazil), while ST617 isolates have been described in Asia (China, Korea, and Taiwan), and Europe (France and Italy). Alternatively, ST4 isolates have been reported in Arabia Saudi [ 68 ]. It is noteworthy that at present, there is no information regarding the prevalence or distribution of E. coli ST410 and ST617 lineages in Mexico, and the unique report of a single human-derived ETEC strain belonging to the ST4 lineage is by Saldaña-Ahuactzi et al [ 69 ].…”
Section: Discussionmentioning
confidence: 99%
“…The major clonal group was composed of ST359 and its double-locus variant, ST101, included six isolates. Both ST359 and ST101 have been previously reported among mcr -positive isolates of human and animal origin in Asia, Europe, Americas and Oceania [ 67 ]. The two K. pneumoniae isolates with mcr-1 were assigned to ST307 and ST23, which are both known as international ‘high-risk clones’ and have been commonly found in clinical settings in Russia [ 68 , 69 , 70 , 71 , 72 , 73 ].…”
Section: Discussionmentioning
confidence: 99%